As of 3:59pm ET
| +0.21 / +3.47%|
The 5 analysts offering 12-month price forecasts for Inovio Pharmaceuticals Inc have a median target of 11.00, with a high estimate of 13.00 and a low estimate of 9.00. The median estimate represents a +75.72% increase from the last price of 6.26.
The current consensus among 5 polled investment analysts is to Buy stock in Inovio Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.